1. Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., Parks C.G., Gilkeson G.S.. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus.
Arthritis Rheum 41:1998;1714–1724.
2. Rahman A., Isenberg D.A.. Systemic lupus erythematosus.
N Engl J Med 358:2008;929–939.
3. D'Cruz D.P., Khamashta M.A., Hughes G.R.. Systemic lupus erythematosus.
Lancet 369:2007;587–596.
4. http://www.lupus.org/webmodules/webarticlesnet/templates/new_learnunderstanding.aspx?articleid=2237&zoneid=523.
5. Yung S., Chan T.M.. Anti-DNA antibodies in the pathogenesis of lupus nephritis–the emerging mechanisms.
Autoimmun Rev 7:2008;317–321.
6. Tsao B.P.. Update on human systemic lupus erythematosus genetics.
Curr Opin Rheumatol 16:2004;513–521.
7. Nath S.K., Kilpatrick J., Harley J.B.. Genetics of human systemic lupus erythematosus: the emerging picture.
Curr Opin Immunol 16:2004;794–800.
8. Wong M., Tsao B.P.. Current topics in human SLE genetics.
Springer Semin Immunopathol 28:2006;97–107.
9. Harley J.B., Kelly J.A., Kaufman K.M.. Unraveling the genetics of systemic lupus erythematosus.
Springer Semin Immunopathol 28:2006;119–130.
10. Iyer S.S., Cheng G.. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.
Crit Rev Immunol 32:2012;23–63.
11. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E.. Il-10 inhibits cytokine synthesis by human monocytes: autoregulatory role of IL10 by monocytes. J Exp Med 174:1991;1209–1220.
12. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J.. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.
Proc Natl Acad Sci U S A 89:1992;1890–1893.
13. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Morel-Fourrier B., Brouet J.C., Alarcon-Segovia D., Galanaud P., Emilie D.. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
J Exp Med 181:1995;839–844.
14. Ding L., Linsley P.S., Huang L.Y., Germain R.N., Shevach E.M.. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.
J Immunol 151:1993;1224–1234.
15. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J.E.. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
J Exp Med 174:1991;915–924.
16. de Waal Malefyt R., Yssel H., de Vries J.E.. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
J Immunol 150:1993;4754–4765.
17. Taga K., Tosato G.. IL-10 inhibits human T cell proliferation and IL-2 production.
J Immunol 148:1992;1143–1148.
18. Eskdale J., Kube D., Tesch H., Gallagher G.. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence.
Immunogenetics 46:1997;120–128.
19. doi:10.1371/journal.pone.0069547.
20. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M.. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.
J Exp Med 179:1994;305–310.
21. Lauwerys B.R., Garot N., Renauld J.C., Houssiau F.A.. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
Arthritis Rheum 43:2000;1976–1981.
22. Llorente L., Richaud-Patin Y., García-Padilla C., Claret E., Jakez-Ocampo J., Cardiel M.H., Alcocer-Varela J., Grangeot-Keros L., Alarcón-Segovia D., Wijdenes J., Galanaud P., Emilie D.. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.
Arthritis Rheum 43:2000;1790–1800.
23. Llorente L., Richaud-Patin Y., Couderc J., Alarcon-Segovia D., Ruiz-Soto R., Alcocer-Castillejos N., Alcocer-Varela J., Granados J., Bahena S., Galanaud P., Emilie D.. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.
Arthritis Rheum 40:1997;1429–1435.
24. Petri M., Orbai A.M., Alarcón G.S., Gordon C., Merrill J.T., Fortin P.R., Bruce I.N., Isenberg D., Wallace D.J., Nived O., Sturfelt G., Ramsey-Goldman R., Bae S.C., Hanly J.G., Sánchez-Guerrero J., Clarke A., Aranow C., Manzi S., Urowitz M., Gladman D., Kalunian K., Costner M., Werth V.P., Zoma A., Bernatsky S., Ruiz-Irastorza G., Khamashta M.A., Jacobsen S., Buyon J.P., Maddison P., Dooley M.A., van Vollenhoven R.F., Ginzler E., Stoll T., Peschken C., Jorizzo J.L., Callen J.P., Lim S.S., Fessler B.J., Inanc M., Kamen D.L., Rahman A., Steinsson K., Franks A.G. Jr., Sigler L., Hameed S., Fang H., Pham N., Brey R., Weisman M.H., McGwin G. Jr., Magder L.S.. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Arthritis Rheum 64:2012;2677–2686.
25. Howard M., O'Garra A., Ishida H., de Waal Malefyt R., de Vries J.. Biological properties of interleukin 10.
J Clin Immunol 12:1992;239–247.
26. Weening J.J., D'Agati V.D., Schwartz M.M., Seshan S.V., Alpers C.E., Appel G.B., Balow J.E., Bruijn J.A., Cook T., Ferrario F., Fogo A.B., Ginzler E.M., Hebert L., Hill G., Hill P., Jennette J.C., Kong N.C., Lesavre P., Lockshin M., Looi L.M., Makino H., Moura L.A., Nagata M.; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Kidney Int 65:2004;521–530.
27. Moroni G., Radice A., Giammarresi G., Quaglini S., Gallelli B., Leoni A., Li Vecchi M., Messa P., Sinico R.A.. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
Ann Rheum Dis 68:2009;234–237.
28. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., Kimberly R.P.. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus.
J Immunol 166:2001;3915–3922.
29. Mehrian R., Quismorio F.P. Jr., Strassmann G., Stimmler M.M., Horwitz D.A., Kitridou R.C., Gauderman W.J., Morrison J., Brautbar C., Jacob C.O.. Synergistic effect between IL-10 and bcl-2 genotypes in deteminig susceptibility to systemic lupus erythematosus.
Arthritis Rheum 41:1998;596–602.
30. Lit L.C., Wong C.K., Tam L.S., Li E.K., Lam C.W.. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.
Ann Rheum Dis 65:2006;209–215.
31. Park Y.B., Lee S.K., Kim D.S., Lee J., Lee C.H., Song C.H.. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
Clin Exp Rheumatol 16:1998;283–288.
32. Zhu L.J., Liu Z.H., Zeng C.H., Chen Z.H., YU C., Li L.S.. Association of interleukin-10 gene-592 A/C polymorphism with the clinical and pathological diversity of lupus nephritis.
Clin Exp Rheumatol 23:2005;854–860.
33. Mok C.C., Lanch bury J.S., Chan D.W., Lau C.S.. Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus.
Arthritis Rheum 41:1998;1090–1095.
34. Beebe A.M., Cua D.J., de Waal Malefyt R.. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).
Cytokine Growth Factor Rev 13:2002;403–412.